PAOLETTI, RODOLFO
 Distribuzione geografica
Continente #
EU - Europa 8.633
AS - Asia 6.745
NA - Nord America 6.342
SA - Sud America 653
AF - Africa 125
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 4
Totale 22.523
Nazione #
US - Stati Uniti d'America 6.111
GB - Regno Unito 3.524
CN - Cina 2.055
SG - Singapore 1.840
IT - Italia 1.177
DE - Germania 819
SE - Svezia 778
RU - Federazione Russa 716
HK - Hong Kong 546
VN - Vietnam 523
BR - Brasile 481
IN - India 418
TR - Turchia 347
NL - Olanda 328
FR - Francia 315
BD - Bangladesh 284
KR - Corea 284
UA - Ucraina 271
FI - Finlandia 195
IE - Irlanda 191
CA - Canada 159
EU - Europa 157
JP - Giappone 105
ID - Indonesia 96
GR - Grecia 85
CO - Colombia 58
AR - Argentina 52
PL - Polonia 47
ES - Italia 45
CI - Costa d'Avorio 36
BE - Belgio 29
PH - Filippine 29
IQ - Iraq 28
MX - Messico 26
ZA - Sudafrica 25
PK - Pakistan 24
TW - Taiwan 23
AT - Austria 19
TH - Thailandia 19
DK - Danimarca 18
AE - Emirati Arabi Uniti 15
AU - Australia 15
EC - Ecuador 15
SA - Arabia Saudita 15
EG - Egitto 13
MY - Malesia 13
UZ - Uzbekistan 12
CL - Cile 11
PT - Portogallo 10
RS - Serbia 10
KE - Kenya 9
NP - Nepal 9
VE - Venezuela 9
AZ - Azerbaigian 8
CH - Svizzera 8
HR - Croazia 8
IL - Israele 8
IR - Iran 8
JM - Giamaica 8
MA - Marocco 8
NO - Norvegia 8
PY - Paraguay 8
TT - Trinidad e Tobago 8
PE - Perù 7
JO - Giordania 6
TN - Tunisia 6
UY - Uruguay 6
HN - Honduras 5
NZ - Nuova Zelanda 5
SV - El Salvador 5
BG - Bulgaria 4
CZ - Repubblica Ceca 4
DZ - Algeria 4
KZ - Kazakistan 4
AL - Albania 3
AM - Armenia 3
BB - Barbados 3
BO - Bolivia 3
EE - Estonia 3
ET - Etiopia 3
LU - Lussemburgo 3
MD - Moldavia 3
OM - Oman 3
PA - Panama 3
PS - Palestinian Territory 3
RO - Romania 3
BH - Bahrain 2
BN - Brunei Darussalam 2
BS - Bahamas 2
BY - Bielorussia 2
BZ - Belize 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GT - Guatemala 2
GY - Guiana 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LV - Lettonia 2
Totale 22.639
Città #
Southend 3.296
Singapore 1.021
Hong Kong 519
Ashburn 500
Chandler 439
San Jose 439
Seattle 379
Beijing 348
Princeton 281
Milan 272
Wilmington 262
Council Bluffs 244
Santa Clara 207
Dublin 190
Redmond 188
Hanover 173
Mountain View 158
Jacksonville 153
Los Angeles 150
Ann Arbor 137
Dallas 130
Sakarya 130
Nanjing 125
Bengaluru 118
Ho Chi Minh City 118
Dearborn 115
Lauterbourg 112
Boardman 108
Fairfield 108
Guangzhou 107
Dong Ket 102
Buffalo 101
Des Moines 99
Woodbridge 98
Shanghai 87
New York 83
Serra 83
Hanoi 82
Jinan 79
Houston 78
Moscow 75
Frankfurt am Main 71
Tokyo 62
Athens 61
Helsinki 61
Berlin 58
Redwood City 57
Eitensheim 54
The Dalles 54
Shenyang 53
Nanchang 51
Andover 50
Cangzhou 49
Hefei 48
Somerville 48
Toronto 48
Bogotá 47
Hebei 44
Jakarta 44
Tianjin 43
Changsha 40
Ottawa 39
Hangzhou 37
Abidjan 36
Seoul 36
Columbus 35
São Paulo 35
Bitonto 33
Cambridge 32
Phoenix 32
Warsaw 31
Grafing 30
Zhengzhou 30
Jiaxing 27
Shenzhen 27
Falls Church 25
Kiez 25
London 25
Perugia 25
Ponte San Pietro 25
Ningbo 23
Rome 23
San Diego 23
Fuzhou 22
Brussels 21
Roxbury 21
Washington 20
Nuremberg 19
Chengdu 18
Belo Horizonte 17
Centro 17
Haikou 17
Haiphong 17
Amsterdam 16
Quanzhou 16
Chicago 15
Istanbul 15
Mumbai 15
Munich 15
Atlanta 14
Totale 13.486
Nome #
Safety of statins: focus on clinical pharmacokinetics and drug interactions 866
Activation of NF-kB and ERK1/2 after permanent focal ischemia is abolished by simvastatin treatment 535
Acute-phase proteins before cerebral ischemia in stroke-prone rats : identification by proteomic 416
Proapoptotic effect of atorvastatin on stimulated rabbit smooth muscle cells 362
HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages 350
Polymorphonuclear leukocyte–myocyte interaction : an early event in collar-induced rabbit carotid intimal thickening 295
Analysis of pathological events at the onset of brain damage in stroke-prone rats: a proteomics and magnetic resonance imaging approach 294
Carotid intima media thickness as marker of atherosclerosis: results of the IMPROVE study 277
Ajoene, a garlic compound, inhibits protein prenylation and arterial smooth muscle cell proliferation 268
Interazioni tra leucociti polimorfonucleati e monociti : un evento primario nell'ispassimento intimale indotto dall'applicazione del collarino alla caraotide di coniglio 265
Pharmacological control of the mevalonate pathway: Effect on arterial smooth muscle cell proliferation 260
Inhibition of smooth muscle cell migration and proliferation by statins 248
Relation between hemostatic variables and increase of common carotid intima-media thickness in patients with peripheral arterial disease 248
The PLAT Study : a multidisciplinary study of hemostatic function and conventional risk factors in vascular disease patients 245
Levels of the n-3 fatty acid eicosapentaenoic acid in addition to those of alpha linolenic acid are significantly raised in blood lipids by the intake of four walnuts a day in humans 243
Direct antiatherogenic activity of isradipine and lacidipine on neointimal lesions induced by perivascular manipulation in rabbits 236
DIFFERENTIAL SENSITIVITY TO MORPHINE-INDUCED ANALGESIA AND MOTOR-ACTIVITY IN 2 INBRED STRAINS OF MICE - BEHAVIORAL AND BIOCHEMICAL CORRELATIONS 234
Platelets and arachidonic acid metabolism in human and experimental hypercholesterolemia 233
Multiexponential T2-relaxation analysis in cerebrally damaged rats in the absence and presence of a gadolinium contrast agent. 232
Non-lipid-related effects of 3-hydroxy-3-methylglutaryl coenzyme A Reductase inhibitors 232
Clinically relevant pleiotropic effects of statins: drug properties or effects of profound cholesterol reduction? 232
CAROTID INTIMA-MEDIA THICKNESS (C-IMT) : BIOMARKER, SURROGATE END POINT OR BOTH? 228
Cross-sectional analysis of baseline data to identify the major determinants of carotid intima-media thickness in a European population : the IMPROVE study 217
Effect of lacidipine on the carotid intimal hyperplasia induced by cuff injury 216
The new calcium antagonist lercanidipine and its enantiomers affect major processes of atherogenesis in vitro: is calcium entry involved? 213
Inhibition of isoprenoid biosynthesis and arterial smooth muscle cell proliferation 212
A consensus document on the role of breakfast in the attainment and maintenance of health and wellness 211
Lipid and non-lipid effects of statins 210
Assessment of nutritional profiles : a novel system based on a comprehensive approach 210
Treatment with statins after induction of focal ischemia in rats reduces the extent of brain damage 210
Metabolic syndrome, inflammation and atherosclerosis 209
Biomarkers for atherosclerosis: pathophysiological role and pharmacological modulation 207
Rosuvastatin displays anti-atherothrombotic and anti-inflammatory properties in apoE-deficient mice 207
Statins effect on smooth muscle cell proliferation 207
Vascular smooth muscle and atherosclerosis: role of isoprenoids and calcium antagonists 197
Calcium antagonists and low density lipoproteins metabolism by human fibroblasts and by human hepatoma cell line HEP G2 197
Effect of S(-) perillic acid on protein prenylation and arterial smooth muscle cell proliferation 197
Interadventitia Common Carotid Artery Diameter Improves Carotid IMT Ability to Predict Coronary Events : Data from the IMPROVE Study : Carotid Intima Media Thickness (IMT) and IMT Progression as Predictors of Vascular Events in a High-Risk European Population 195
Effect of lacidipine on fatty and proliferative lesions induced in hypercholesterolaemic rabbits 189
Non-pharmacological control of plasma cholesterol levels 189
Macromolecular drugs II. Effects of a polymer bound nicotinic acid on experimentally induced hyperlipemia in the rat 189
Direct Effects of Statins on the Vascular Wall 189
Direct vascular effects of HMG-CoA reductase inhibitors 188
Carotid intima media thickness (IMT) and IMT-progression as predictors of vascular events in a high risk european population: the Improve study 187
HMGCoA reductase inhibitors: in vivo effects on carotid intimal thickening in normocholesterolemic rabbits 186
Bridging science and health policy in cardiovascular disease: focus on lipid management : a Report from a Session held during the 7th International Symposium on Multiple Risk Factors in Cardiovascular Diseases: Prevention and Intervention – Health Policy, in Venice, Italy, on 25 October, 2008 186
Controle pharmacologique de la voie de biosynthese du mevalonate: effet sur la proliferation de cellules musculaires lisses arterielles 186
Serum from hypercholesterolemic patients treated with atorvastatin or simvastatin inhibits cultured human smooth muscle cell proliferation 185
Rosuvastatin provides anti-inflammatory effects and end-organ protection in stroke-prone rats 183
Lalsoacidipine modulates the secretion of matrix metalloproteinase-9 by human macrophages 182
SYNTHESIS AND PHARMACOLOGICAL CHARACTERIZATION OF 2-(4-CHLORO-3-HYDROXYPHENYL)ETHYLAMINE AND N,N-DIALKYL DERIVATIVES AS DOPAMINE RECEPTOR LIGANDS 181
New insights into the pharmacodynamic and pharmacokinetic properties of statins 180
Progression of Carotid Intima-Media Thickness as Predictor of Vascular Events: Results from the IMPROVE Study 179
Safety considerations for statins 176
EUFEPS report. Contribution of academic research to discovery and development of medicines : current status and future opportunities 175
LACIDIPINE: IN VIVO EFFECTS ON INTIMAL CAROTID THICKENING IN HYPERCHOLESTEROLAEMIC RABBITS 175
CAROTID INTIMA MEDIA THICKNESS (IMT) AND IMT-PROGRESSION AS PREDICTORS OF VASCULAR EVENTS IN A HIGH RISK EUROPEAN POPULATION : THE IMPROVE STUDY 172
Dietary interventions in north Karelia, Finland and south Italy. Modification of thromboxane B2 formation in platelets of male subjects only 171
Pleiotropic effects of statins in atherosclerosis and diabetes 171
Rosuvastatin, but not simvastatin, provides end-organ protection in stroke-prone rats by antiinflammatory effects 170
Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging 170
Lipid-modified proteins as biomarkers for cardiovascular disease: a review 168
Therapeutic significance of hypolipidemic and antiatherosclerotic drugs 167
Dual effects of the antioxidant agents probucol and carvedilol on proliferative and fatty lesions in hypercholesterolemic rabbits 167
GYKI 14,451, a synthetic tripeptide inhibitor of thrombin: activity on platelet aggregation and arachidonic acid metabolism 166
Non-lipid-related effects of statins 164
Sera from patients treated with fluvastatin XL inhibit human arterial myocyte proliferation 163
Recombinant apolipoprotein A-IMilano for the treatment of cardiovascular diseases 162
The emerging link between nutrition, inflammation and atherosclerosis 162
Inhibitor of proliferation of arterial smooth-muscle cells by fluvastatin 162
Safety of Dyslipidemic Agents 160
EFFECT OF THE NEW HMG-CoA REDUCTASE INHIBITOR CERIVASTATIN (BAY W 6228) ON MIGRATION, PROLIFERATION AND CHOLESTEROL SYNTHESIS IN ARTERIAL MYOCYTES 160
Rosuvastatin reduces inflammation and atherothrombosis in apoE-deficient mice 159
Simvastatin but not pravastatin has a direct inhibitory effect on rat and human myocyte proliferation 157
Atherosclerosis and thrombosis. Old and new drugs 157
Treatment of hypertriglyceridemia with metformin. Effectiveness and analỳsis of results 156
Effect of derivatives of trapidil on the expression of LDL receptors 155
Vastatins inhibit tissue factor in cultured human macrophages. A novel mechanism of protection against atherothrombosis 150
Trapidil derivatives and low density lipoprotein metabolism by human skin fibroblasts and by human hepatoma cell line Hep G2 148
Farmacologia delle statine: evidenze di un'azione antiaterosclerotica diretta 147
Control of human and animal platelet aggregation by a new prostacyclin analog 147
The pharmacological control of the mevalonate pathway regulates arterial smooth muscle cell proliferation 147
Ability of simvastatin to inhibit DNA synthesis in PDGF-BB-, EGF-, LPA- and ET-1- stimulated smooth muscle cells. 145
Effects of compactin (ML-236 B) on biliary lipid composition and cholesterol catabolism in the hamster 144
Experimental and clinical effects of isradipine relevant to atherosclerosis 144
New insights into brain damage in stroke-prone rats: a nuclear magnetic imaging study 143
Influence of bezafibrate, fenofibrate, nicotinic acid and etofibrate on plasma high-density lipoprotein levels 141
GYKI 14,451, a synthetic tripeptide inhibitor of thrombin: "in vitro" and "in vivo" studies 141
Vastatin inhibit tissue factor expression by human macrophages 141
Simvastatin but not pravastatin inhibits the proliferation of rat aorta myocytes 140
Pharmacological control of myocyte proliferation by different farnesyltransferase inhibitors 140
CAROTID INTIMA MEDIA THICKNESS (IMT) AND IMT-PROGRESSION AS PREDICTORS OF VASCULAR EVENTS IN A HIGH RISK EUROPEAN POPULATION: “THE IMPROVE STUDY” 139
Ultrasonographic measurement of the common carotid artery wall thickness in hypercholesterolemic patients. A new model for the quantitation and follow-up of preclinical atherosclerosis in living human subjects 138
Vastatin inhibit tissue factor expression by human macrophages: involvement of the mevalonate pathway 137
The binding of 2,3,7,8-tetrachlorodibenzodioxin to plasma lipoproteins may delay toxicity in experimental hyperlipidemia 136
Intima media thickness and vascular risk factors for the recognition of patients at high risk of atherosclerosis 135
Studies on the antithrombotic action of BOC-D-PHE-PRO-ARG-H (GYKI 14,451) 134
Mevalonate pathway and isoprenoids regulate human bronchial myocyte proliferation 133
New strategies in the development of anti-atherosclerotic drugs 132
Ability of simvastatin to inhibit DNA synthesis of PDGF-BB-, EGF-, and LPA-stimulated smooth muscle cells. 130
Totale 20.090
Categoria #
all - tutte 57.575
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.575


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.662 188 62 60 72 89 144 118 141 220 163 140 265
2022/20231.732 233 141 167 213 213 323 42 82 186 21 61 50
2023/2024987 47 91 67 40 226 52 26 53 23 95 134 133
2024/20252.662 115 253 52 299 205 119 106 320 116 259 205 613
2025/20265.807 463 301 668 408 538 482 672 398 692 415 425 345
2026/2027213 213 0 0 0 0 0 0 0 0 0 0 0
Totale 23.670